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Background: Rehabilitation after spinal cord injury (SCI) has traditionally involved teaching compensatory strategies
for identified impairments and deficits in order to improve functional independence. There is some evidence that
regular and intensive activity-based therapies, directed at activation of the paralyzed extremities, promotes
neurological improvement. The aim of this study is to compare the effects of a 12-week intensive activity-based
therapy program for the whole body with a program of upper body exercise.
Methods/Design: A multicenter, parallel group, assessor-blinded randomized controlled trial will be conducted.
One hundred eighty-eight participants with spinal cord injury, who have completed their primary rehabilitation at
least 6 months prior, will be recruited from five SCI units in Australia and New Zealand. Participants will be
randomized to an experimental or control group. Experimental participants will receive a 12-week program of
intensive exercise for the whole body, including locomotor training, trunk exercises and functional electrical
stimulation-assisted cycling. Control participants will receive a 12-week intensive upper body exercise program. The
primary outcome is the American Spinal Injuries Association (ASIA) Motor Score. Secondary outcomes include
measurements of sensation, function, pain, psychological measures, quality of life and cost effectiveness. All
outcomes will be measured at baseline, 12 weeks, 6 months and 12 months by blinded assessors. Recruitment
commenced in January 2011.
Discussion: The results of this trial will determine the effectiveness of a 12-week program of intensive exercise for
the whole body in improving neurological recovery after spinal cord injury.
Trial registration: NCT01236976 (10 November 2010), ACTRN12610000498099 (17 June 2010).
Keywords: Spinal cord injury, Randomized controlled trial, Exercise, Locomotor training, FESBackground
Rehabilitation after spinal cord injury (SCI) has been
traditionally based on expectations regarding functional
outcomes predicted by the initial level of injury and
severity of impairment [1]. It has relied substantially on
compensatory strategies for identified impairments and
deficits that were considered irremediable, because sig-
nificant recovery of motor function was not expected
beyond that defined by clinical assessments [2]. Thus, in* Correspondence: m.galea@unimelb.edu.au
1Department of Medicine (Royal Melbourne Hospital), The University of
Melbourne, Parkville, VIC 3010, Australia
Full list of author information is available at the end of the article
© 2013 Galea et al.; licensee BioMed Central L
Commons Attribution License (http://creativec
reproduction in any medium, provided the orpatients with clinically complete injuries, therapy has
been primarily directed at activities to improve func-
tional independence, e.g., teaching new strategies to
move in bed and transfer into and out of a wheelchair,
and provision of assistive devices [2]. This strategy is re-
liant on strengthening muscles above the spinal lesion
level and using leverage, momentum and substitution to
move weak or paralyzed parts of the body. While this
approach results in improvements of independent
function, it does not promote recovery of motor control
in the paralyzed limbs [3]. In addition, because of
funding limitations available for in-patient rehabilitation,td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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needs for independence in preparation for discharge [2].
Regular physical activity through upper body training is
effective in improving cardiorespiratory fitness, muscle
strength [4,5] and psychological well-being in the SCI
population [6]. However, there is new evidence that regu-
lar and intensive activity-based therapies, directed at acti-
vation of the paralyzed extremities, promotes neurological
improvement [2,7-9]. These therapies include partial
body-weight-supported locomotor training (LT), func-
tional electrical stimulation (FES)-assisted leg exercise,
and exercises to improve control of trunk and lower
limb musculature. To date, the interventions have been
investigated as single entities; however, Harness et al. [9]
conducted a study involving a combination of these inter-
ventions. They reported that people with spinal cord in-
jury receiving intensive exercises focused on attempting to
regain voluntary motor function below the level of injury
showed improvement in motor function, whereas those
undertaking a self-directed exercise program did not show
any improvements. However, the study had a number
of limitations, including a non-randomized design and
significant difference between groups in time post-injury.
While most research attention has focused on the ben-
efits of these types of therapy for people with incomplete
lesions [10,11], those with complete lesions may also
benefit since it is recognized that many people with
complete injuries are electrophysiologically incomplete
(discomplete) [12,13]. In these cases, patients who
are clinically paralyzed show sub-clinical evidence of
translesional motor connections [14]. These subclinical
responses can take various forms, for example, repeat-
able responses to reinforcement maneuvers or to strong
vibration [15] or the ability to volitionally suppress re-
sponses evoked by plantar surface stimulation [16,17].
The objective of this project, therefore, is to determine
the effectiveness of an intensive activity-based therapy
program for patients with complete and incomplete
spinal cord lesions. This will involve LT, FES-assisted leg
cycling as well as trunk, upper limb and lower extremity
exercises. In the case of complete spinal cord injury, LT
will be used to explore the potential for stimulating
neurological improvement rather than as a means of
attaining functional ambulation [18]. The control inter-
vention will comprise solely upper body exercises.
Methods
The trial has been registered on ClinicalTrials.gov
(NCT01236976) and the Australian and New Zealand
Clinical Trials Registry (ACTRN12610000498099).
Funding
The study is being funded by the Transport Accident
Commission (Victorian Neurotrauma Initiative), the LifeTime Care and Support Authority (NSW), The Univer-
sity of Melbourne and The University of Western
Australia. Further funding for equipment was obtained
from the Premier’s Science and Research Fund, South
Australia, SpinalCure Australia, and the CatWalk Trust,
New Zealand. At the conclusion of the trial, all equip-
ment purchased for the trial will be gifted to the partici-
pating hospitals.
Design
A multicenter, assessor-blinded, randomized controlled
trial will be conducted. Experimental group participants
will undertake an intensive 12-week program of whole
body exercise, including their paralyzed lower limbs,
while control group participants will undertake an upper
body strength and aerobic fitness training program over
the same period. The trial will be conducted in six spinal
units in Australia and New Zealand. Ethical approval has
been obtained from the Human Research Ethics Com-
mittee at each site (see Additional files 1 and 2) and at
the University of Melbourne (HREC 1034730). Partici-
pants will be provided with information sheets, and
written informed consent will be obtained prior to
recruitment and baseline assessment.
Participants
One hundred eighty-eight participants who are at least
6 months post-spinal cord injury will be recruited through
referral by medical practitioners or therapists from one of
the six participating spinal cord injury units involved or
through advertisements placed in newsletters of Spinal
Cord Injuries Australia, Independence Australia, on the
SCIPA website (http://www.scipa.unimelb.edu.au) and col-
laborator websites. Those interested in participating will
undergo an initial telephone screening survey comprising
questions relating to their medical history and the proto-
col inclusion and exclusion criteria.
Inclusion criteria
Participants will be included if they:
1. Have sustained a traumatic spinal cord injury a
minimum of 6 months prior to consent and have
completed their primary rehabilitation
2. Are 18 years or older and able to give informed
consent
3. Have a complete or incomplete spinal cord injury
between C6 and T12 (as per the International
Standards for Neurological Classification of SCI [19]
4. Are able and willing to attend an exercise program
three times per week for 12 weeks
5. Are considered by their medical consultant to be fit
to undertake the exercise program (documented
approval by medical consultant required).
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Participants will not be included if they:
1. Have brachial plexus, cauda equina or peripheral
nerve injury
2. Have had recent major trauma or surgery within the
last 6 months
3. Have an existing stage 3 or 4 pressure ulcer
according to the National Pressure Ulcer Advisory
Panel classification [20]
4. Are post-menopausal at the time of injury (females)
5. Have a BMI at injury falling below the lower
threshold of the healthy adult reference range
6. Have endocrinopathy or metabolic disorders of the
bone, such as Paget’s disease, lytic or renal bone
disease, and senile osteoporosis
7. Have a medical history of exposure to medication
(s) known to affect mineral or bone metabolism
8. Have chronic systemic diseases, e.g., hepatitis C or
HIV-AIDS
9. Have significant impairment or disability, including
physical, neurological or psychological impairments,
additional to the spinal cord injury
10. Have a history of long bone fracture or family
history of fragility fracture
11. Have medical fragility, e.g., a BMI falling below
the lower threshold of the healthy adult
reference range, or history of recurrent hospital
readmissions
12. Have extensive fixed contractures in the upper or
lower limbs
13. Have severe spasticity
14. Have uncontrolled neuropathic pain
15. Are likely to experience clinically significant
autonomic dysreflexia and/or orthostatic
hypotension in response to electrical stimulation or
prolonged upright postures
16. Are unable to attend the 6- and 120 month follow-
up assessments at their treating spinal unit
17. Have any contraindications to FES such as a cardiac
pacemaker, epilepsy, lower limb fracture or
pregnancy
18. Have intracranial metal implants
19. Have any other serious medical condition including
malignancies, psychiatric, behavioral or drug-
dependency problems, which are likely to influence
the participant’s ability to cooperate or in the
opinion of the study investigator would prevent
adherence to the protocol
20. Are participating in any other therapy (including
alternative therapies) or taking medications
(including herbal preparations) that are not
considered to be standard care as per the
protocol.Randomization
Participants will be randomly assigned to either the ex-
perimental or control group with a 1:1 allocation as per
a computer-generated randomization schedule stratified
by site and injury status [American Spinal Injuries Asso-
ciation Impairment Scale (AIS) A/B or AIS C/D]. The
randomization schedule will be under the control of a
central randomization unit, independent of the trial, lo-
cated at Neuroscience Trials Australia. A participant will
be considered to have entered the trial once his/her
randomization is revealed.
Intervention
All participants will attend the assigned exercise pro-
gram for 36 sessions over 12 weeks, with an intended
frequency of thrice weekly.
Experimental group
Participants in the experimental group will receive a
triad of interventions comprising locomotor training,
FES-assisted cycling as well as trunk and upper and
lower extremity exercises. These interventions will be
provided at the participating spinal units.
Locomotor training will be provided using a Theras-
tride system (Innoventor, Inc., St Louis, MO, USA). Par-
ticipants will be assisted to stand on the treadmill in an
upright position and suspended in a harness by an over-
head pulley at the maximum load necessary to avoid the
knees collapsing into flexion. A therapist/assistant will
be positioned behind the participant to stabilize the
pelvis and trunk, as well as to assist weight shifting and
hip rotation during the step cycle. This person will
ensure that the trunk and pelvis are not flexed or
hyperextended during stepping. Two therapists/assis-
tants will be seated in front and to the side of the par-
ticipant to provide manual assistance for the lower limbs
to facilitate knee extension during stance and knee
flexion and toe clearance during swing, maintaining ap-
propriate alignment of the limbs. Manual assistance will
be used as needed. Another therapist/assistant will con-
trol the treadmill. During the session, the treadmill
speed will be adjusted to promote the best stepping pat-
tern at the given body weight load. Speed will be pro-
gressively increased as appropriate to a normal walking
speed range (0.89-1.34 m•s-1). Over the course of the
study, the amount of body weight support can be re-
duced gradually as the participants improve their ability
to bear weight on the lower limbs [21].
FES-assisted cycling will be provided using a RT300
cycle (Restorative Therapies, Baltimore, MD, USA). Sur-
face electrodes will be applied over the belly of the quad-
riceps, gluteal and hamstrings muscles according to a
standardized protocol. The pedal cadence will be set to
15–50 rev•min-1. Stimulation intensity will be gradually
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of 0.3 ms at a frequency of 35 Hz [22,23]. Participants
will exercise at the maximal power output possible at
their level of recovery. They will undertake 30 min of
cycling, initially in intermittent periods of exercise with
rest breaks, but progressing to longer continuous exer-
cise as deemed appropriate by supervising therapist/
assistant. The frequency, power output, interval times
and total training duration will be recorded at each
training session.
Trunk and upper and lower limb exercises will com-
prise assisted and/or resisted movements aimed at facili-
tating and strengthening voluntary muscle activity and
improving movement quality. These may be provided
in lying (e.g., supine, prone, semi-recumbent) and in
weight-bearing postures (e.g., kneeling, standing). Task-
specific practice of functional tasks, involving moving
the upper body over and outside the base of support,
will also be undertaken. Participants may also be given
exercises in motor imagery, i.e., imagining movements of
their body [24]. Project staff will use their clinical judg-
ment to select exercises suitable for each participant and
to progress them as appropriate. All exercises selected
will be documented in the participant source notes.
Control participants
Participants in the control group will receive an upper
body strength and fitness program provided three times
per week for 12 weeks. This program may be provided
at the spinal unit or an appropriately equipped gymna-
sium as approved by the Project Committee. The
program will be a circuit-based exercise program incorp-
orating resistance and cardiorespiratory training. For this
protocol, the circuit will comprise several stations using
different pieces of equipment and with minimal time to
rotate between stations. The participants will be super-
vised by a therapist and/or clinical exercise instructor,
and exercises will be progressed as appropriate to build
strength and endurance in the intensity range of 6–20
repetition maximum (RM). Exercises could include hand
cycling, chest press, boxing, lateral pull-downs and
rowing. Guidelines for the content and delivery of exer-
cises will be clearly outlined in a handbook to ensure
standardization across sites.
Wash-out and follow-up period
For 3 weeks prior to the intervention, participants will
cease any formal intensive exercise programs in which
they are participating. During the program, participants
will not undertake any formal intensive exercise pro-
grams in addition to those provided in the study proto-
col. At the end of the 12-week intervention period, there
will be no restriction placed on participants with respect
to undertaking further exercise.Quality assurance
To ensure that treatments are of a high standard and de-
livered in accordance with the trial protocol, therapists
responsible for the administration of the exercise pro-
grams will attend workshops where they will be trained
in the delivery of the treatment program and in assess-
ment procedures. The workshops will cover locomotor
training (4 days), FES-assisted cycling training (2 days),
trunk training (2 days), upper body training (1 day) and
assessment procedures (1 day). Therapists will also be
provided with a written protocol, and standardized case
report forms for documentation of assessments and
interventions provided.
Outcome assessments
Assessments will occur at baseline, 12 weeks after the
commencement of the intervention, and then at 6 months
and 12 months after randomization. All assessments will
be undertaken by therapists blinded to group allocation.
Any inadvertent unblinding of assessors will be reported.
In addition, the success of blinding will be estimated by
asking assessors to guess the participant’s group allocation
at the completion of each post-randomization assessment.
Primary outcome
The primary outcome measure is the American Spinal
Injuries Association (ASIA) motor score at 12 weeks
The ASIA Motor Score is derived from part of the assess-
ment for the International Standards for Neurological
Classification of Spinal Cord Injury [19]. It involves testing
the strength of ten key muscles on each side of the body in
the supine position (e.g., elbow flexors, wrist extensors, hip
flexors, quadriceps, dorsiflexors) on a scale of 0 = no con-
traction to 5 = normal resistance through full range of mo-
tion. Scores are summed to give a total possible score of 50
for the upper extremities and 50 for the lower extremities.
Secondary outcome measures are:
ASIA motor and sensory scores at 6 months and 12 months
The ASIA Motor Assessment will be undertaken as de-
scribed above. The ASIA Sensory assessment is also part
of the assessment for the International Standard for
Neurological Classification of Spinal Cord Injury. It in-
volves testing pinprick and light touch sensation at key
points representing each dermatome. Pin-prick and light-
touch sensation of each dermatome is separately scored
on a 3-point scale (0, 1 and 2). Scores will be summed to
give a total possible score of 224 where a higher score in-
dicates better sensation than a lower score.
Leg exercise capacity test at 12 weeks, 6 months and
12 months
Participants will perform a graded exercise test using
their legs (FES cycling), following the protocol of
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amplitude will be increased manually from the lowest
current amplitude that evokes minimum muscle contrac-
tion up to 100% amplitude of the cycle’s stimulator output
(~140 mA). The timing of FES stimulation current ampli-
tude increments will be based on the prevailing heart rate
response between resting heart and age-predicted max-
imum heart rate. The measures of interest will be change
of peak power output (W), peak heart rate (b•min-1) and
change of sub-maximal heart rate (b•min-1) during the
20 W and 40 W stages and during the incremental portion
of the leg cycling.
Spinal cord independence measure (SCIM) at 12 weeks,
6 months and 12 months
The SCIM was designed specifically for patients with
spinal cord injuries. It focuses on the spinal cord injured
person’s ability to perform basic everyday tasks and takes
into consideration the economic burden of disability as
well as the impact of disability on the participant’s over-
all medical condition and comfort [26,27]. The SCIM
consists of three complementary subscales: ‘Self care,’
‘Respiration and sphincter management’ and ‘Mobility’.
Anthropometry at 12 weeks, 6 months and 12 months
Body mass index (BMI) will be estimated from body
mass and lying stature. Skin fold calipers will be used to
assess change in body adiposity at 12 sites on the body
while the participant is lying horizontal [28]. Abdominal
circumference, chest circumference and leg circumfer-
ences will be assessed at the greatest girth-points.
Measures of trunk function at 12 weeks, 6 months and
12 months
Maximal balance range [29] will be measured by asking
participants to reach as far forward as they can without
falling and then return to their starting position. The
distance reached will be measured using a sway meter, a
40-cm hinged rod fastened by a firm belt to the partici-
pants’ chest at the level of the axilla and extending in
a horizontal plane from the body. A ballpoint pen
mounted at the end of the rod will record the move-
ments of the upper body on a sheet of graph paper fixed
to the top of a height-adjustable table with a meter-long
ruler taped to the side. The resultant trace will be mea-
sured in terms of the maximal anteroposterior (AP)
displacement in centimeters traversed by the pen. The
participants will have two attempts at the test, with the
longer distance (maximal AP distance moved) taken as
the test result. A long distance is considered a better
performance. This score will be corrected for body
height (score × mean height/participants’ height) mea-
sured from the center of the sway meter strap to the top
of the seat.The Spinal Cord Injury-Falls Concern Scale (SCI-FCS)
[30] is a questionnaire adapted from the Falls Efficacy
Scale-International [31] and worded appropriately for
activities undertaken by people in wheelchairs. Partici-
pants will be asked to record on a 4-point scale how
concerned they are about falling when performing each
activity. A score of 1 reflects ‘not at all concerned’ and a
score of 4 reflects ‘very concerned.’ Scores on each item
will be summed.
Spasticity at 12 weeks, 6 months and 12 months
Spasticity over the previous week will be measured via
self-report using the Penn Spasm Frequency Score
(PSFS) [32,33]:
0 = No spasms
1 = Spasms induced by stimulation
2 = Spasms occurring less than once per hour
3 = Spasms occurring more than once per hour
4 = Spasms occurring more than 10 times per hour
Any change in the dosage of anti-spasticity medication
during the intervention period will also be monitored.
Multidimensional pain inventory (spinal cord injury version)
at 12 weeks, 6 months and 12 months
Pain will be measured using the spinal cord injury
version of the Multidimensional Pain Inventory (SCI-
MPI) [34,35]. This is a comprehensive instrument
designed to assess a range of self-reported behavioral
and psychosocial factors associated with chronic pain
syndromes and has been validated in the spinal cord
injury population.
Walking tests at 12 weeks, 6 months and 12 months
Walking tests will be conducted only in participants cap-
able of ambulation. The 6-Minute Walk Test (6MWT) is
a self-paced task that measures the distance that a par-
ticipant can walk in 6 min. The participant may stop to
rest at any point. The test may be performed either in-
doors or outdoors, along a long, flat, straight and hard
surface, preferably 30 m in length, marked every 3 m,
with a turnaround point marked with a cone. The dis-
tance (total distance walked rounded to the nearest
meter) will be measured. The fatigue level will also be
reported.
The 10 Meter Walk Test (10MWT) measures the time
required to walk 10 m. Participants will walk at their
preferred walking speed. They may use an assistive de-
vice and must wear shoes. To minimize the effects of ac-
celeration and deceleration, participants will commence
walking at least 2 m before the start of the 10 m walking
track and continue for 2 m beyond the end of the track
(14 m altogether). The time (seconds) will be measured
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in m•s-1.
Psychological measures at 12 weeks, 6 months and
12 months
Stress will be measured using the Perceived Stress Scale
(PSS) [36], which is the most widely used psychological
instrument for measuring the perception of stress.
Depression will be measured using the Hospital Anxiety
and Depression Scale (HADS) [37]. Physical Self-
Concept will be measured using the Multidimensional
Health Locus of Control [38]. Self-Efficacy will be mea-
sured using the Moorong Self-Efficacy Scale [39,40] and
Self Esteem using the Rosenberg Self-Esteem Scale [41].
All of these tools have previously been used in people
with spinal cord injury.
Quality of life at 12 weeks, 6 months and 12 months
The Health Utilities Index Mark 3 (HUI3) is a measure
of health-related quality of life widely used around the
world in population health surveys, clinical studies and
cost-utility analyses. HUI3 includes eight attributes
(vision, hearing, speech, ambulation, dexterity, emotion,
cognition and pain), with five or six levels for each attri-
bute. The HUI3 is able to discriminate various aspects
of burden associated with chronic conditions as well as
describing the differences in overall health-related qual-
ity of life levels [42]. In addition, the Assessment of
Quality of Life (AQoL)-8, which is a self-administered
8-item questionnaire [43], is also used for two reasons.
One is that this instrument was developed relatively
more recently based on the utility value of Australian
population. The other is to provide an alternative source
of information from a different instrument.
The WHOQoL-Bref questionnaire was designed by an
international collaboration on quality of life by the
World Health Organization. It contains 26 questions
about many different aspects of quality of life, with some
additional questions about the person and his/her health.
It has been found to be a valid measure in people with
spinal cord injury [44].
Economic outcomes
Economic evaluation will determine whether the experi-
mental intervention is cost-effective compared to the
control intervention. The incremental cost-effectiveness
analysis will measure incremental costs in the two
groups in relation to the AIS Motor score, divided by
the incremental change in health utility and quality of
life measures. This study employs a societal perspective.
Therefore, all relevant costs associated with participants
and delivery of experimental and control interventions
will be included. The cost of treatment will be estimated
using standard costs for therapy and actual costs oftraining equipment expressed as a mean cost of treat-
ment per participant. Community-based resource use
from the time of randomization will include data on
visits to GPs, specialists or other health care providers,
pharmaceutical costs, as well as data on resource use
specifically relating to levels of independent functioning
(aids, equipment, community services, e.g., home help,
home maintenance, meals on wheels, transport, formal
and informal care, cost of home modifications, etc.). The
potential loss of productivity of the participant will also
be measured.
Treatment effectiveness will be determined by the pri-
mary endpoint, as well as the health utility and quality
of life measures. Cost-effectiveness will be calculated as
the cost per patient treated. These calculations will be
based on the number of participants effectively treated
in the intervention group minus the number of partici-
pants who also meet the criteria of ‘effectively treated’ in
the control group. Lifetime cost and effectiveness will be
modeled using decision-tree and Markov processes.
Statistical analyses
Sample size
This power analysis is for a one-way fixed effects ana-
lysis of covariance with two levels that correspond to
experimental and control arms of the study. This ana-
lysis includes baseline value of AIS Motor Score as a
covariate and uses week 12 values as the primary out-
come. Available pilot data [9] demonstrate a mean
change in the AIS Motor Score of 4.8 (SD = 1.0) in an
intensive exercise group compared to a mean change of
0.1 (SD = 0.5) points in the control group from the com-
parable baseline of 40. Assuming the more conservative
difference in mean changes in AIS Motor Score between
the groups of 4.0, a similar baseline mean AIS Motor
score of 40 and a correlation between the baseline and
week 12 ASIA Motor score of 0.8, the resulting analysis
of covariance effect size (f ) is 0.22. The corresponding
total sample size of 150 participants equally distributed
between experimental and control arms will yield power
of 0.8 to reject the null hypothesis at a 0.05 level of
significance. The analysis of variance is non-directional
(i.e., two-tailed), which means that an effect in either dir-
ection will be interpreted. Allowing for 20% dropout
rate, the final sample size for this study is calculated to
be 188 patients equally distributed between experimental
and control arms.
Statistical analysis
The primary and secondary endpoints analyses will be
conducted by an independent statistician on an intention-
to treat basis and using the full data set comprising all ran-
domized participants. In addition, a per protocol analysis
of the primary outcome will be reported. The data set for
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aspects of the protocol and received at least 80% of the
training sessions. Multiple imputation of missing values
will be conducted. All variables will be expressed as
means, SD or median (IQR), unless otherwise indicated.
Baseline comparisons between the two arms of the study
will be made using means or medians and proportions
with 95% confidence intervals as appropriate.
All endpoints and analyses have been prospectively
categorized as either primary or secondary. Differences
in both primary and secondary endpoints between the
two arms of the study will be tested independently at the
0.05 level of significance, using a one-way ANCOVA
model that will include the baseline value of the given
outcome in question as a covariate. No formal adjust-
ments will be undertaken to constrain the overall type I
error associated with the secondary analyses. Their pur-
pose is to supplement evidence from the confirmatory
primary analysis to help more fully characterize the
treatment effect. Results from the secondary analyses
will be interpreted in this context.
Data integrity and management
Data will be stored electronically on a database with
secured and restricted access. Data transfer will be
encrypted and any information capable of identifying
individuals removed.
Withdrawals
A participant will be considered to have withdrawn from
the trial when consent is revoked or if the participant
cannot be contacted or located. If this occurs, no further
assessments will be performed. Participants will not be
withdrawn from the trial for protocol violations.
Monitoring
The trial will be overseen and monitored by a Program
Manager. The Program Manager will visit each site to
examine trial procedures, ensure data quality and moni-
tor compliance with the trial protocol. All adverse events
and serious adverse events will be recorded according to
standard procedures. Three safety variables will be mon-
itored and documented throughout the trial. These are
self-reported pain (using an 11-point category rating
scale), blood pressure and skin irritation from the stimu-
lating electrodes or body weight support harness. How-
ever, only two safety variables (pain and blood pressure)
are considered serious enough to warrant inclusion in
two unblinded safety interim analyses. These analyses
will be undertaken when 60 and then 120 participants
have completed the post-intervention assessment. It will
be done by an Independent Data Safety Monitoring
Board comprising a statistician and two rehabilitation
doctors. If there are concerns about the safety ofparticipants, this board will make a recommendation to
the trial steering committee about continuing, stopping
or modifying the trial. The Haybittle-Peto procedure for
generating early stopping boundaries will be used for
pain and blood pressure. A recommendation of early
termination for safety reasons because of pain (mean
margin of 4/10) or blood pressure (mean margin of
40 mmHg) will be considered by the Independent Data
Safety Monitoring Board if the corresponding Haybittle-
Peto boundary (p = 0.003, Z = 3) at a given interim ana-
lysis is crossed. No formal interim analyses for efficacy
or futility are planned.Discussion
This trial will provide information about the effective-
ness of an intensive full-body exercise program in pro-
moting neurological improvement. This is important for
understanding the therapeutic effect of rehabilitation
independent of drug or cellular interventions, since
rehabilitation may confound the outcome of these inter-
ventions [45]. The mechanisms by which exercise pro-
grams improve function after SCI also need to be better
understood because they allow for development of new
and more effective therapeutic strategies. In this study,
the control intervention is not standard care but an ac-
tive intervention, involving an intensive exercise pro-
gram for the upper body. This ensures that the intensity
and group dynamics of the both exercise programs are
similar, so that the effects of adding exercise of the para-
lyzed lower limbs can be identified.
This trial will adhere to key methodological principles
important for minimizing bias (International Conference
on Harmonisation Good Clinical Practice annotated by
the Therapeutic Goods Administration of Australia) [46]
and will be reported according to the CONSORT guide-
lines [47]. For example, allocation will be concealed and
randomized, assessors will be blinded, and analyses will
be performed on an intention-to-treat basis. Therapists
and participants will not be blinded because of the
nature of the intervention. One primary outcome and
a number of secondary outcomes will be used. The
primary outcome reflects neurological function. The
secondary outcomes include measures of impairment,
activity limitation and participation restriction, and en-
compass both objective measures as well as participants’
perceptions. Importantly, all adverse events will be rigor-
ously documented so that the safety of the interventions
can be evaluated. It is anticipated that this trial will take
3 years to complete.Trial status
Recruitment commenced in January 2011, with the first
participant randomized in February 2011. Recruitment
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follow-up assessments will be completed in 2014.
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